610 A validation study of modified TCGA classification for patients with endometrial cancer treated with radical surgery and adjuvant chemotherapy
Hiroyuki Yamazaki(Hokkaido University), Hidemichi Watari(Hokkaido University of Science), Kanako C. Hatanaka(Hokkaido University Hospital), Yosuke Konno(Hokkaido University of Science), Kei Ihira(Hokkaido University), Yutaka Hatanaka(Hokkaido University), Hiroshi Asano(Hokkaido University), Daisuke Endo(Gifu University), Ryosuke Matsuoka(International University of Health and Welfare), Tatsuya Kato(Hokkaido University), Takashi Mitamura(Sapporo University)
Cited by 0
Related Papers
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
|Cancer Research|2016|178
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
|Journal of Experimental & Clinical Cancer Research|2019|164
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
|Oncotarget|2014|155
The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
|Journal of Translational Medicine|2014|129
MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
|Journal of Experimental & Clinical Cancer Research|2016|123